Neumora Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -160 | -158 | -166 | |
EBITDA | -76,490 | -63,662 | -59,916 | -100,294 |
EBIT | -76,646 | -63,822 | -60,074 | -100,460 |
Net Income | -72,547 | -58,700 | -53,721 | -108,730 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -32,708 | -56,158 | -43,730 | -51,486 |
Cash | 275,714 | 150,678 | 182,927 | 374,038 |
Basic Shares | 159,576 | 158,984 | 157,943 | 158,830 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -668 | -2,697 | -1,551 | |
EBITDA | -187,526 | -135,276 | -236,785 | -95,413 |
EBIT | -188,194 | -137,973 | -238,336 | -95,518 |
Net Income | -235,925 | -130,904 | -237,312 | -99,272 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -163,395 | -115,407 | -76,237 | -28,060 |
Cash | 374,038 | 240,943 | 409,247 | 191,977 |
Basic Shares | 158,832 | 151,949 | 151,949 | 151,949 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.45 |
2024-06-30 | -$0.37 |
2024-03-31 | -$0.34 |
2023-12-31 | -$0.71 |
